Innate Pharma: Funding, Investors & Team (Sep 2026)
Innate Pharma S.A. is a biopharmaceutical company that is creating new immunotherapy drugs for cancer and inflammatory diseases. They focus on developing unique monoclonal antibodies that target receptors and pathways that regulate the activation of cells of the innate immune system. Their groundbreaking methods have resulted in collaborations with Novo Nordisk A/S and Bristol-Myers Squibb.
Innate Pharma has raised $57.4M across 3 funding rounds on record, the most recent an undisclosed round of $17.0M announced in Apr 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Innate Pharma Company Profile and Key Stats
Latest funding round on record: Apr 2025.
Innate Pharma Funding Rounds
Innate Pharma raised $32.5M in a Post-IPO Debt announced in Jan 2022.
2.9 years later, an undisclosed round of $7.9M was announced in Dec 2024.
4 months later, an undisclosed round of $17.0M was announced in Apr 2025.
Innate Pharma Founders and Leadership Team
Contact details for the Innate Pharma team: 1 of 3 have an email address on file.
Start 14-day free trial →Innate Pharma Funding Compared to Other Biotechnology Startups
Innate Pharma's latest round of $17.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Innate Pharma in Biotechnology and Marseille
Companies Similar to Innate Pharma
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Innate Pharma Funding FAQs
What does Innate Pharma do?
Innate Pharma S.A. is a biopharmaceutical company that is creating new immunotherapy drugs for cancer and inflammatory diseases. They focus on developing unique monoclonal antibodies that target receptors and pathways that regulate the activation of cells of the innate immune system. Their groundbreaking methods have resulted in collaborations with Novo Nordisk A/S and Bristol-Myers Squibb.
How much funding has Innate Pharma raised?
Innate Pharma has raised $57.4M across 3 rounds on record. The most recent is an undisclosed round of $17.0M announced in Apr 2025.
When did Innate Pharma last raise funding?
Innate Pharma's most recent funding round on record is an undisclosed round of $17.0M, announced in Apr 2025.
Who founded Innate Pharma?
FundedIQ lists Herve Brailly (Founder), Marc Bonneville (Founder) at Innate Pharma.
Who is the CEO of Innate Pharma?
Mondher Mahjoubi is listed as CEO at Innate Pharma.
Where is Innate Pharma headquartered?
Innate Pharma is based in Marseille, Provence-Alpes-Cote D'azur, France.
How many employees does Innate Pharma have?
Innate Pharma is in the 101-250 employee band.
How does Innate Pharma's funding compare to other Biotechnology startups?
Innate Pharma's latest round of $17.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Innate Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Innate Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.